- Investing Ideas
- U.S. Pharmaceuticals & Biotech Buy the Dip
U.S. Pharmaceuticals & Biotech Buy the Dip
Results
2
2 new
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
2 companies
Indivior Pharmaceuticals
Market Cap: US$4.3b
Engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
New
INDV
US$35.97
7D
-8.8%
1Y
47.1%
OnKure Therapeutics
Market Cap: US$155.9m
A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases.
New
OKUR
US$3.85
7D
-8.6%
1Y
40.0%